Edwards Lifesciences Corporation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases
Edwards Lifesciences Corporation (EW) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases of $7.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases · last filed 2026-08-04
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2026-06-30 was $0.00.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2026-03-31 was $7.90M.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2024-12-31 was $12.70M.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2021-12-31 was $0.00.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2024 was $16.50M.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2021 was $14.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $7.90M 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $7.90M 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $16.50M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $3.80M 10-Q · filed 2025-11-05 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $14.00M 10-K · filed 2023-02-13 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $14.00M 10-Q · filed 2022-10-28 | ||
| 2021-06-30 | $14.00M 10-Q · filed 2022-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |